{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:58:32Z","timestamp":1781089112973,"version":"3.54.1"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:p>\n                    This study aimed to examine the causal relationship between metformin treatment and the prevention of various cancer types through a 2-sample Mendelian randomization (MR) analysis. Utilizing genome-wide association study summary data, a 2-sample MR approach was employed to assess the association between metformin treatment and multiple cancer types. The analysis further investigated the causal effects of specific metformin targets, including adenosine monophosphate-activated protein kinase (AMPK), mitochondrial complex I, mitochondrial glycerol 3-phosphate dehydrogenase, and growth differentiation factor 15 (GDF15). Causal associations were evaluated using inverse-variance weighting, MR-Egger, weighted median, and Wald ratio methods. Sensitivity analyses were performed using the TwoSampleMR package in R to ensure robustness. inverse-variance weighting estimates demonstrated a protective effect of metformin against esophageal, gastric, and colorectal cancers (all odds ratios\u2005&lt;0.1, all\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;.05). The Wald ratio analysis identified a significant causal association between GDF15 and colorectal cancer (odds ratios: 0.927, 95% confidence interval: 0.883\u20130.974,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.003). However, no significant causal relationships were observed between the other metformin targets and the aforementioned cancers. All single-nucleotide polymorphisms used as instrumental variables exhibited strong associations, and no evidence of horizontal pleiotropy was detected. The findings provide genetic evidence supporting a potential protective role of metformin against the development of esophageal, gastric, and colorectal cancers. Furthermore, our analysis suggests that the protective effect of metformin on colorectal cancer might be partially mediated by GDF15, which warrants further investigation.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047322","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:02:10Z","timestamp":1769191330000},"page":"e47322","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Metformin treatment and reduction of gastrointestinal cancer risk: A 2-sample Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"given":"Dongcun","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Minimally Invasive Intervention, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fujun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Intervention, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Minimally Invasive Intervention, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260610","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","article-title":"Current cancer epidemiology.","volume":"9","author":"Mattiuzzi","year":"2019","journal-title":"J Epidemiol Glob Health"},{"key":"R2-20260610","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrclinonc.2013.169","article-title":"Beyond aspirin-cancer prevention with statins, metformin and bisphosphonates.","volume":"10","author":"Gronich","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"R3-20260610","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/dc14-0500","article-title":"Metformin and cancer: mounting evidence against an association.","volume":"37","author":"Suissa","year":"2014","journal-title":"Diabetes Care"},{"key":"R4-20260610","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients.","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"R5-20260610","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1055-9965.EPI-10-0940","article-title":"Metformin and the incidence of prostate cancer in patients with type 2 diabetes.","volume":"20","author":"Azoulay","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R6-20260610","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.2337\/dc12-2535","article-title":"Association between metformin therapy and mortality after breast cancer: a population-based study.","volume":"36","author":"Lega","year":"2013","journal-title":"Diabetes Care"},{"key":"R7-20260610","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jnci\/djt170","article-title":"Association between metformin use and risk of prostate cancer and its grade.","volume":"105","author":"Margel","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"R8-20260610","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nrgastro.2015.9","article-title":"Gastric cancer. Metformin improves survival and recurrence rate in patients with diabetes and gastric cancer.","volume":"12","author":"Greenhill","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R9-20260610","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.2337\/dc13-1489","article-title":"Incidence of bladder cancer in patients with type 2 diabetes treated with metformin or sulfonylureas.","volume":"37","author":"Mamtani","year":"2014","journal-title":"Diabetes Care"},{"key":"R10-20260610","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.metabol.2013.01.014","article-title":"Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.","volume":"62","author":"Thakkar","year":"2013","journal-title":"Metabolism"},{"key":"R11-20260610","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.ajkd.2021.04.018","article-title":"Coffee and caffeine consumption and risk of kidney stones: a mendelian randomization study.","volume":"79","author":"Yuan","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"R12-20260610","doi-asserted-by":"crossref","first-page":"e35191","DOI":"10.1097\/MD.0000000000035191","article-title":"Causal association of metformin and osteoporosis: a 2-sample Mendelian randomization study.","volume":"102","author":"Wei","year":"2023","journal-title":"Medicine (Baltim)"},{"key":"R13-20260610","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data.","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"R14-20260610","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes.","volume":"53","author":"Sakaue","year":"2021","journal-title":"Nat Genet"},{"key":"R15-20260610","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s00125-022-05743-0","article-title":"Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer\u2019s disease risk in the general population: a Mendelian randomisation study.","volume":"65","author":"Zheng","year":"2022","journal-title":"Diabetologia"},{"key":"R16-20260610","doi-asserted-by":"crossref","first-page":"e1006706","DOI":"10.1371\/journal.pgen.1006706","article-title":"Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.","volume":"13","author":"Folkersen","year":"2017","journal-title":"PLoS Genet"},{"key":"R17-20260610","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome.","volume":"558","author":"Sun","year":"2018","journal-title":"Nature"},{"key":"R18-20260610","doi-asserted-by":"crossref","first-page":"14357","DOI":"10.1038\/ncomms14357","article-title":"Connecting genetic risk to disease end points through the human blood plasma proteome.","volume":"8","author":"Suhre","year":"2017","journal-title":"Nat Commun"},{"key":"R19-20260610","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1038\/s41467-018-05512-x","article-title":"Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease.","volume":"9","author":"Yao","year":"2018","journal-title":"Nat Commun"},{"key":"R20-20260610","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1126\/science.aaq1327","article-title":"Co-regulatory networks of human serum proteins link genetics to disease.","volume":"361","author":"Emilsson","year":"2018","journal-title":"Science"},{"key":"R21-20260610","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.aaz1776","article-title":"The GTEx Consortium atlas of genetic regulatory effects across human tissues.","volume":"369","year":"2020","journal-title":"Science"},{"key":"R22-20260610","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12863-022-01082-6","article-title":"Pulmonary embolism and 529 human blood metabolites: genetic correlation and two-sample Mendelian randomization study.","volume":"23","author":"Feng","year":"2022","journal-title":"BMC Genom Data"},{"key":"R23-20260610","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R24-20260610","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R25-20260610","doi-asserted-by":"crossref","first-page":"9160","DOI":"10.1002\/cam4.3493","article-title":"Depression and prostate cancer risk: a Mendelian randomization study.","volume":"9","author":"Chen","year":"2020","journal-title":"Cancer Med"},{"key":"R26-20260610","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/ije\/dyz218","article-title":"Mendelian randomization study showed no causality between metformin use and lung cancer risk.","volume":"49","author":"Zhou","year":"2020","journal-title":"Int J Epidemiol"},{"key":"R27-20260610","doi-asserted-by":"crossref","first-page":"e000872","DOI":"10.1136\/bmjdrc-2019-000872","article-title":"Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.","volume":"7","author":"Au Yeung","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R28-20260610","doi-asserted-by":"crossref","first-page":"18802","DOI":"10.18632\/oncotarget.13390","article-title":"Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.","volume":"8","author":"Tseng","year":"2017","journal-title":"Oncotarget"},{"key":"R29-20260610","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2337\/dc11-0512","article-title":"Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis.","volume":"34","author":"Zhang","year":"2011","journal-title":"Diabetes Care"},{"key":"R30-20260610","doi-asserted-by":"crossref","first-page":"55622","DOI":"10.18632\/oncotarget.16973","article-title":"Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies.","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"R31-20260610","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2337\/dc12-0740","article-title":"The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.","volume":"36","author":"Smiechowski","year":"2013","journal-title":"Diabetes Care"},{"key":"R32-20260610","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/mc.23692","article-title":"Drug\u2010target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.","volume":"63","author":"Sun","year":"2024","journal-title":"Mol Carcinog"},{"key":"R33-20260610","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13098-023-01218-3","article-title":"Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis.","volume":"15","author":"Chen","year":"2023","journal-title":"Diabetol Metab Syndrome"},{"key":"R34-20260610","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1470-2045(16)00006-1","article-title":"Metformin for cancer prevention: a reason for optimism.","volume":"17","author":"Chan","year":"2016","journal-title":"Lancet Oncol"},{"key":"R35-20260610","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/1120009X.2022.2091122","article-title":"Combination of mTOR inhibitor PP242 and AMPK activator metformin exerts enhanced inhibitory effects on colorectal carcinoma cells in vitro by blocking multiple kinase pathways.","volume":"35","author":"Sun","year":"2023","journal-title":"J Chemother"},{"key":"R36-20260610","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc16-1682","article-title":"Growth Differentiation factor 15 as a novel biomarker for metformin.","volume":"40","author":"Gerstein","year":"2017","journal-title":"Diabetes Care"},{"key":"R37-20260610","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41586-019-1911-y","article-title":"GDF15 mediates the effects of metformin on body weight and energy balance.","volume":"578","author":"Coll","year":"2020","journal-title":"Nature"},{"key":"R38-20260610","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2337\/dci22-0047","article-title":"Metformin and cancer: solutions to a real-world evidence failure.","volume":"46","author":"Yu","year":"2023","journal-title":"Diabetes Care"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:02:40Z","timestamp":1781085760000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047322","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"2025-08-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-16","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}